Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor
- PMID: 15809491
Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor
Abstract
The biologic mechanisms involved in the intratumoral heterogeneous distribution of 18F-FDG have not been fully investigated. To clarify factors inducing heterogeneous 18F-FDG distribution, we determined the intratumoral distribution of 18F-FDG by autoradiography (ARG) and compared it with the regional expression levels of glucose transporters Glut-1 and Glut-3 and hexokinase-II (HK-II) in a rat model of malignant tumor.
Methods: Rats were inoculated with allogenic hepatoma cells (KDH-8) into the left calf muscle (n = 7). Tumor tissues were excised 1 h after the intravenous injection of 18F-FDG and sectioned to obtain 2 adjacent slices for ARG and histochemical studies. The regions of interest (ROIs) were placed on ARG images to cover mainly the central (CT) and peripheral (PT) regions of viable tumor tissues and necrotic/apoptotic (NA) regions. The radioactivity in each ROI was analyzed quantitatively using a computerized imaging analysis system. The expression levels of Glut-1, Glut-3, and HK-II were determined by immunostaining and semiquantitative evaluation. The hypoxia-inducible factor 1 (HIF-1) was also immunostained.
Results: ARG images showed that intratumoral 18F-FDG distribution was heterogeneous. The accumulation of 18F-FDG in the CT region was the highest, which was 1.6 and 2.3 times higher than those in the PT and NA regions, respectively (P < 0.001). The expression levels of Glut-1, Glut-3, and HK-II were markedly higher in the CT region (P < 0.001) compared with those in the PT region. The intratumoral distribution of 18F-FDG significantly correlated with the expression levels of Glut-1, Glut-3, and HK-II (r = 0.923, P < 0.001 for Glut-1; r = 0.829, P < 0.001 for Glut-3; and r = 0.764, P < 0.01 for HK-II). The positive staining of HIF-1 was observed in the CT region.
Conclusion: These results demonstrate that intratumoral 18F-FDG distribution corresponds well to the expression levels of Glut-1, Glut-3, and HK-II. The elevated expression levels of Glut-1, Glut-3, and HK-II, induced by hypoxia (HIF-1), may be contributing factors to the higher 18F-FDG accumulation in the CT region.
Similar articles
-
Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma.Ann Nucl Med. 2008 Jan;22(1):83-6. doi: 10.1007/s12149-007-0076-1. Ann Nucl Med. 2008. PMID: 18250992
-
Relationship between glucose transporter, hexokinase and FDG-PET in esophageal cancer.Hepatogastroenterology. 2005 Mar-Apr;52(62):486-90. Hepatogastroenterology. 2005. PMID: 15816463
-
2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II.Acta Radiol. 2008 Dec;49(10):1145-53. doi: 10.1080/02841850802482486. Acta Radiol. 2008. PMID: 18979289
-
The rate-limiting step for tumor [18F]fluoro-2-deoxy-D-glucose (FDG) incorporation.Nucl Med Biol. 2001 Jan;28(1):1-4. doi: 10.1016/s0969-8051(00)00177-3. Nucl Med Biol. 2001. PMID: 11182558 Review. No abstract available.
-
FDG uptake, tumour characteristics and response to therapy: a review.Nucl Med Commun. 1998 Feb;19(2):97-105. doi: 10.1097/00006231-199802000-00002. Nucl Med Commun. 1998. PMID: 9548192 Review.
Cited by
-
Prognostic value of tumoral heterogeneity and volumetric parameters as measured by F18-FDG PET/CT in sinonasal cancer.Eur Arch Otorhinolaryngol. 2017 Mar;274(3):1437-1443. doi: 10.1007/s00405-016-4346-1. Epub 2016 Oct 17. Eur Arch Otorhinolaryngol. 2017. PMID: 27747383
-
FDG--a marker of tumour hypoxia? A comparison with [18F]fluoromisonidazole and pO2-polarography in metastatic head and neck cancer.Eur J Nucl Med Mol Imaging. 2006 Dec;33(12):1426-31. doi: 10.1007/s00259-006-0175-6. Epub 2006 Jul 14. Eur J Nucl Med Mol Imaging. 2006. PMID: 16841141
-
Low glucose metabolism in hepatocellular carcinoma with GPC3 expression.World J Gastroenterol. 2018 Jan 28;24(4):494-503. doi: 10.3748/wjg.v24.i4.494. World J Gastroenterol. 2018. PMID: 29398870 Free PMC article.
-
Choline kinase alpha and hexokinase-2 protein expression in hepatocellular carcinoma: association with survival.PLoS One. 2012;7(10):e46591. doi: 10.1371/journal.pone.0046591. Epub 2012 Oct 5. PLoS One. 2012. PMID: 23071593 Free PMC article.
-
Evaluation of organ glucose metabolism by 18F-FDG accumulation with insulin loading in aged mice compared with young normal mice.Sci Rep. 2021 Apr 1;11(1):7421. doi: 10.1038/s41598-021-86825-8. Sci Rep. 2021. PMID: 33795778 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous